Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Frazier Life Sciences Acquisition Corp. II

FLSC · — · CIK 0002153598 · Shell Companies · Shell Companies

INSIDER SIGNAL

60.3 / 100

1 buyers · 1 purchase transaction lines · $3.0M gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeStrong
RoleModerate
RecencyStrong
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+20.8 / 25
Role+13.0 / 20
Recency+9.5 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ✓ Recent activity · latest purchase 2026-10-15

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Cha Albert; FHMLSP, L.L.C.; FHMLSP, L.P.; Frazier Life Sciences Holdings II LLC; Frazier Life Sciences Public Fund, L.P.Chief Executive Officer
●
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: Cha Albert; FHMLSP, L.L.C.; FHMLSP, L.P.; Frazier Life Sciences Holdings II LLC; Frazier Life Sciences Public Fund, L.P. · $3.0M
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-10-15–2026-10-15

Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

60.3 / 100

Latest recorded score

↓ -0.4 ptsversus the previous recorded snapshot
  1. 60.7
  2. 60.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

1Purchases
0Sales
0Other Form 4 lines
1SEC filings · 365 days
BUYING1 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
—
3M
—
6M
—
12M
—

Volatility & liquidity

Volatility
—
Beta
—
Avg daily value
—

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
—
ROE
—
Industry
Shell Companies

Market data

Price data up to: 2026-10-18 · Price source: OpenBB/yfinance · Status: PASS

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Cha Albert; FHMLSP, L.L.C.; FHMLSP, L.P.; Frazier Life Sciences Holdings II LLC; Frazier Life Sciences Public Fund, L.P.Purchase (P)Class A ordinary shares300,000USD 10.00USD 3,000,000SEC filing ↗

Form 4 evidence

1 transaction lines in the latest 365-day window; 1 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Cha Albert; FHMLSP, L.L.C.; FHMLSP, L.P.; Frazier Life Sciences Holdings II LLC; Frazier Life Sciences Public Fund, L.P.Purchase (P)Class A ordinary shares300,000USD 10.00USD 3,000,000SEC filing ↗
Show recent Form 4 evidence (1 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Cha Albert; FHMLSP, L.L.C.; FHMLSP, L.P.; Frazier Life Sciences Holdings II LLC; Frazier Life Sciences Public Fund, L.P.Purchase (P)Class A ordinary shares300,000USD 10.00USD 3,000,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityREVIEW MAPPING_REVIEW · mapping-review-required
TickerFLSC
CIK0002153598
SectorShell Companies
IndustryShell Companies Yahoo Finance
SEC SIC6770 Blank Checks
Exchange—

Data coverage

Local Form 4 history1 transaction lines from 2026-10-15 to 2026-10-15
1 P purchase lines · 0 S sale lines · 0 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.